{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T11:11:52Z","timestamp":1789038712020,"version":"build-2803163510"},"reference-count":38,"publisher":"MDPI AG","issue":"18","license":[{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Clin. Med.","JCM"],"abstract":"<jats:p>Atrial fibrillation (AF) is a major cause of cardioembolic stroke, and oral anticoagulation (OAC) remains the standard of care for thromboembolic prophylaxis. Because the left atrial appendage (LAA) is the dominant source of thrombus in AF, percutaneous LAA occlusion (LAAO) has been developed as a mechanical alternative for patients in whom long-term anticoagulation is problematic. Randomized trials against warfarin established non-inferiority for the composite endpoint, though not consistently across coprimary endpoints, and more recent trials against direct oral anticoagulants (DOACs) have extended this comparison to post-ablation and lower-risk populations. Across these studies a consistent pattern emerges: the clinical advantage of LAAO derives largely from a reduction in non-procedural bleeding rather than from superior ischemic protection, and recent meta-analyses diverge mainly according to how the thromboembolic endpoint is composed. At the extreme of stroke and bleeding risk, LAAO failed to demonstrate non-inferiority to physician-directed medical care. This review synthesizes the randomized evidence, examines methodological differences in endpoint construction and patient selection that complicate cross-trial comparison, and discusses determinants of procedural success including peridevice leak, device endothelialization, and device-related thrombus. Remaining evidence gaps are outlined, particularly for patients who experience ischemic stroke despite adequate anticoagulation.<\/jats:p>","DOI":"10.3390\/jcm15187015","type":"journal-article","created":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T10:27:21Z","timestamp":1789036041000},"page":"7015","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Left Atrial Appendage Occlusion vs. Oral Anticoagulants: Current Evidence and Debates"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5492-2508","authenticated-orcid":false,"given":"Emir","family":"Baskovski","sequence":"first","affiliation":[{"name":"Department of Cardiology, Ankara University School of Medicine, Ankara 06230, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0961-6755","authenticated-orcid":false,"given":"Halil","family":"Gulyigit","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Ankara University School of Medicine, Ankara 06230, T\u00fcrkiye"},{"name":"Department of Cardiology, Izmir Tepecik Training and Research Hospital, Izmir 35020, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6737-3686","authenticated-orcid":false,"given":"Omer","family":"Akyurek","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Ankara University School of Medicine, Ankara 06230, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timucin","family":"Altin","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Ankara University School of Medicine, Ankara 06230, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8795-9251","authenticated-orcid":false,"given":"Eralp","family":"Tutar","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Ankara University School of Medicine, Ankara 06230, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/s41569-022-00820-8","article-title":"Epidemiology and modifiable risk factors for atrial fibrillation","volume":"20","author":"Elliott","year":"2023","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","article-title":"2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): Developed by the task force for the management of atrial fibrillation of the European Society of Cardiology (ESC), with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Endorsed by the European Stroke Organisation (ESO)","volume":"45","author":"Rienstra","year":"2024","journal-title":"Eur. Heart J."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Aarnink, E., Zabern, M., Boersma, L., and Glikson, M. (2023). Mechanisms and Prediction of Ischemic Stroke in Atrial Fibrillation Patients. J. Clin. Med., 12.","DOI":"10.3390\/jcm12206491"},{"key":"ref_4","first-page":"877","article-title":"The left atrial appendage: From embryology to prevention of thromboembolism","volume":"38","author":"Patti","year":"2017","journal-title":"Eur. Heart J."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Miceli, G., Ciaccio, A.M., and Tuttolomondo, A. (2025). Challenges and Opportunities of Direct Oral Anticoagulant (DOAC) Therapy in Complex Clinical Scenarios: A Comprehensive Review and Practical Guide. J. Clin. Med., 14.","DOI":"10.3390\/jcm14092914"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1161\/CIR.0000000000001193","article-title":"2023 ACC\/AHA\/ACCP\/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"149","author":"Joglar","year":"2024","journal-title":"Circulation"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1056\/NEJMoa2101897","article-title":"Left Atrial Appendage Occlusion during Cardiac Surgery to Prevent Stroke","volume":"384","author":"Whitlock","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"E1048","DOI":"10.1016\/j.hrthm.2025.05.048","article-title":"2025 SCAI\/HRS clinical practice guidelines on transcatheter left atrial appendage occlusion","volume":"22","author":"Goldsweig","year":"2025","journal-title":"Heart Rhythm"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1016\/j.jacc.2017.10.021","article-title":"5-Year Outcomes After Left Atrial Appendage Closure: From the PREVAIL and PROTECT AF Trials","volume":"70","author":"Reddy","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1001\/jama.2014.15192","article-title":"Percutaneous Left Atrial Appendage Closure vs Warfarin for Atrial Fibrillation: A Randomized Clinical Trial","volume":"312","author":"Reddy","year":"2014","journal-title":"JAMA"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2014.04.029","article-title":"Prospective randomized evaluation of the watchman left atrial appendage closure device in patients with atrial fibrillation versus long-term warfarin therapy: The PREVAIL trial","volume":"64","author":"Holmes","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1056\/NEJMoa2408308","article-title":"Left Atrial Appendage Closure after Ablation for Atrial Fibrillation","volume":"392","author":"Wazni","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1056\/NEJMoa2517213","article-title":"Left Atrial Appendage Closure or Anticoagulation for Atrial Fibrillation","volume":"394","author":"Doshi","year":"2026","journal-title":"N. Engl. J. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"4335","DOI":"10.1093\/eurheartj\/ehag333","article-title":"Weekly Journal Scan: Is left atrial appendage closure really non-inferior to anticoagulation in atrial fibrillation?","volume":"47","author":"Liuzzo","year":"2026","journal-title":"Eur. Heart J."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2021.10.023","article-title":"4-Year Outcomes After Left Atrial Appendage Closure Versus Nonwarfarin Oral Anticoagulation for Atrial Fibrillation","volume":"79","author":"Osmancik","year":"2022","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"107273","DOI":"10.1016\/j.ahj.2025.09.005","article-title":"Catheter-based left atrial appendage CLOSURE in patients with atrial fibrillation at high risk of stroke and bleeding as compared to best medical therapy: Rationale and design of the prospective randomized CLOSURE-AF trial","volume":"292","author":"Landmesser","year":"2026","journal-title":"Am. Heart J."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1056\/NEJMoa2513310","article-title":"Left Atrial Appendage Closure or Medical Therapy in Atrial Fibrillation","volume":"394","author":"Landmesser","year":"2026","journal-title":"N. Engl. J. Med."},{"key":"ref_18","first-page":"euag159","article-title":"Long-term efficacy and safety of left atrial appendage closure vs. oral anticoagulation in atrial fibrillation: A meta-analysis of randomized controlled trials","volume":"28","author":"Karakasis","year":"2026","journal-title":"EP Eur."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"102933","DOI":"10.1016\/j.jacadv.2026.102933","article-title":"Left Atrial Appendage Closure vs Direct Oral Anticoagulants in Atrial Fibrillation","volume":"5","author":"Chan","year":"2026","journal-title":"JACC Adv."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Turagam, M.K., Halperin, J.L., Granger, C.B., Bhatt, D.L., Velagapudi, P., Dukkipati, S.R., Gurol, M.E., Sartori, S., Nair, D.G., and Neuzil, P. (2026). Left Atrial Appendage Closure vs Anticoagulation for Stroke Prevention in Atrial Fibrillation: Meta-Analysis of Randomized Trials. JACC Clin. Electrophysiol.","DOI":"10.1016\/j.jacep.2026.06.033"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1001\/jama.2024.3026","article-title":"Pulmonary Vein Isolation With or Without Left Atrial Appendage Ligation in Atrial Fibrillation: The aMAZE Randomized Clinical Trial","volume":"331","author":"Lakkireddy","year":"2024","journal-title":"JAMA"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.4244\/EIJY19M08_01","article-title":"EHRA\/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion\u2014An update","volume":"15","author":"Glikson","year":"2020","journal-title":"EuroIntervention"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/j.jcmg.2025.07.018","article-title":"Outcomes of Left Atrial Appendage Patency After Device Closure Detected by Cardiac CT","volume":"18","author":"Jacquemyn","year":"2025","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"102963","DOI":"10.1016\/j.jacadv.2026.102963","article-title":"Frailty Severity Outcomes After Left Atrial Appendage Occlusion","volume":"5","author":"Badwan","year":"2026","journal-title":"JACC Adv."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1016\/j.jacep.2025.08.014","article-title":"Impact of Device Compression on Peridevice Leak After Left Atrial Appendage Closure: The Impression LAAC Study","volume":"11","author":"Galea","year":"2025","journal-title":"JACC Clin. Electrophysiol."},{"key":"ref_26","first-page":"499","article-title":"Left atrial appendage occlusion in patients suffering from advanced chronic kidney disease (stage 4 and 5). Long-term follow-up","volume":"103","year":"2024","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"L\u00f3pez-Tejero, S., Ant\u00fanez-Mui\u00f1os, P., Fraile-G\u00f3mez, P., Blanco-Fern\u00e1ndez, F., Barreira-de Sousa, G., Herrero-Garibi, J., Rodr\u00edguez-Collado, J., Diego-Nieto, A., del Villar, C.P., and Delgado-Lapeira, G.C. (2025). Left Atrial Appendage Occlusion Compared to Anticoagulation in Patients Suffering from Atrial Fibrillation with Advanced Chronic Kidney Disease. J. Clin. Med., 14.","DOI":"10.3390\/jcm14165709"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1016\/j.jacc.2022.02.047","article-title":"Antithrombotic Therapy After Left Atrial Appendage Occlusion in Patients With Atrial Fibrillation","volume":"79","author":"Freeman","year":"2022","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.jacc.2024.05.067","article-title":"Anticoagulation Alone vs Anticoagulation Plus Aspirin or DAPT Following Left Atrial Appendage Occlusion","volume":"84","author":"Reinhardt","year":"2024","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"877","DOI":"10.4244\/EIJ-D-17-00042","article-title":"Safety and efficacy of early anticoagulation drug regimens after WATCHMAN left atrial appendage closure: Three-month data from the EWOLUTION prospective, multicentre, monitored international WATCHMAN LAA closure registry","volume":"13","author":"Bergmann","year":"2017","journal-title":"EuroIntervention"},{"key":"ref_31","first-page":"101391","article-title":"A real-world multicenter study on left atrial appendage occlusion: The Italian multi-device experience","volume":"51","author":"Procopio","year":"2024","journal-title":"Int. J. Cardiol. Heart Vasc."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1016\/j.jacc.2023.08.010","article-title":"Network Meta-Analysis of Initial Antithrombotic Regimens After Left Atrial Appendage Occlusion","volume":"82","author":"Carvalho","year":"2023","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1161\/CIRCULATIONAHA.121.054305","article-title":"Antithrombotic Therapy in Patients Undergoing Transcatheter Interventions for Structural Heart Disease","volume":"144","author":"Gragnano","year":"2021","journal-title":"Circulation"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1001\/jamaneurol.2024.2882","article-title":"Left Atrial Appendage Occlusion vs Standard of Care After Ischemic Stroke Despite Anticoagulation","volume":"81","author":"Maarse","year":"2024","journal-title":"JAMA Neurol."},{"key":"ref_35","first-page":"140","article-title":"Left atrial appendage occlusion plus oral anticoagulation in stroke patients despite ongoing anticoagulation: Rationale and design of the ADD-LAAO clinical trial","volume":"7","author":"Amaro","year":"2025","journal-title":"REC Interv. Cardiol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ahj.2021.08.020","article-title":"Left atrial appendage occlusion vs novel oral anticoagulation for stroke prevention in atrial fibrillation: Rationale and design of the multicenter randomized occlusion-AF trial","volume":"243","author":"Korsholm","year":"2022","journal-title":"Am. Heart J."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.jacep.2015.06.007","article-title":"Intentional Right Atrial Exit and Carbon Dioxide Insufflation to Facilitate Subxiphoid Needle Entry Into the Empty Pericardial Space: First Human Experience","volume":"1","author":"Greenbaum","year":"2015","journal-title":"JACC Clin. Electrophysiol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"ytag173","DOI":"10.1093\/ehjcr\/ytag173","article-title":"Left atrial appendage occluder thrombosis caused embolic strokes: A case report","volume":"10","author":"Riedemann","year":"2026","journal-title":"Eur. Heart J. Case Rep."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/18\/7015\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T10:48:45Z","timestamp":1789037325000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/18\/7015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,10]]},"references-count":38,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["jcm15187015"],"URL":"https:\/\/doi.org\/10.3390\/jcm15187015","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,10]]}}}